• Loading stock data…

Delmar pharmaceuticals

DelMar Pharmaceutical (NASDAQ: DMPI) Remains On Track Despite COVID-19 Crisis

Recap: Since November of 2019 MS Money Moves has been following DelMar Pharmaceuticals (Nasdaq: DMPI) closely through a number of key value inflection points. In my initial article I … [Read more...] about DelMar Pharmaceutical (NASDAQ: DMPI) Remains On Track Despite COVID-19 Crisis

DelMar Pharmaceuticals (Nasdaq: DMPI) Approaches a Key Inflection Point At the 2019 Society for Neuro-Oncology Annual Meeting

 In my last article I summarized my discussions with DelMar Pharmaceuticals’ (Nasdaq: DMPI) President and CEO Saiid Zarrabian and the value proposition DelMar offers investors. To recap, DelMar … [Read more...] about DelMar Pharmaceuticals (Nasdaq: DMPI) Approaches a Key Inflection Point At the 2019 Society for Neuro-Oncology Annual Meeting

Introducing the New and Improved DelMar Pharmaceuticals (Nasdaq: DMPI)

On September 25th, 2019 the MS Money Moves Executive Leadership Team had an hour long conference call with President and CEO of DelMar Pharmaceuticals (Nasdaq: DMPI) Saiid Zarrabian and acting Chief … [Read more...] about Introducing the New and Improved DelMar Pharmaceuticals (Nasdaq: DMPI)